Henan Medinno Pharmaceutical Technology Co., Ltd. announced that it has raised tens of millions of yuan in pre-A round of funding led by new investor Zhuhai Huajin Capital Co., Ltd. on January 16, 2024. The transaction included participation from new investor Shenzhen Zhongjince Investment Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.21 CNY | +0.23% | +7.75% | +10.18% |
25/04 | Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
27/03 | Zhuhai Huajin Capital Co., Ltd. Announces Profit Distribution Proposal for 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+10.18% | 630M | |
-5.26% | 94.17B | |
+24.48% | 91.27B | |
+19.64% | 27.7B | |
-1.00% | 18.41B | |
+15.26% | 15.55B | |
+4.45% | 15.29B | |
-20.31% | 12.49B | |
+13.56% | 9.3B | |
+24.50% | 9.29B |
- Stock Market
- Equities
- 000532 Stock
- News Zhuhai Huajin Capital Co., Ltd.
- Henan Medinno Pharmaceutical Technology Co., Ltd. announced that it has received funding from Zhuhai Huajin Capital Co., Ltd., Shenzhen Zhongjince Investment Co., Ltd.